C. Give an accelerated course of the hepatitis B vaccine + hepatitis B immune globulin – Explanation
Post-exposure prophylaxis
Hepatitis A
- Human Normal Immunoglobulin (HNIG) or hepatitis A vaccine may be used depending on the
clinical situation
Hepatitis B
- HBsAg positive source: if the person exposed is a known responder to HBV vaccine then a booster
dose should be given. If they are in the process of being vaccinated or are a non-responder they
need to have hepatitis B immune globulin (HBIG) and the vaccine - unknown source: for known responders the green book advises considering a booster dose of HBV
vaccine. For known non-responders HBIG + vaccine should be given whilst those in the process of
being vaccinated should have an accelerated course of HBV vaccine
Hepatitis C
- monthly PCR – if seroconversion then interferon +/- ribavirin
HIV
- a combination of oral antiretrovirals (e.g. Tenofovir, emtricitabine, lopinavir and ritonavir) as soon
as possible (i.e. Within 1-2 hours, but may be started up to 72 hours following exposure) for 4 weeks - serological testing at 12 weeks following completion of post-exposure prophylaxis
- reduces risk of transmission by 80%
Varicella zoster
- VZIG for IgG negative pregnant women/immunosuppressed
Estimates of transmission risk for single needlestick injury
Hepatitis B | 20-30% |
Hepatitis C | 0.5-2% |
HIV | 0.3% |